A retrospective analysis of BMI/TP ratio and its predictive role in gestational hypertension outcomes

Dajun Cai1, Jiahao Tang, Shanshan Gao

  • 1Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province, China.

Medicine
|December 30, 2025
PubMed

Nutritional status and protein metabolism play key roles in maternal adaptation to pregnancy and may influence outcomes in hypertensive disorders of pregnancy. The body mass index to total protein (BMI/TP) ratio may capture the balance between adiposity and protein reserves. This retrospective study included 306 pregnant women diagnosed with gestational hypertension at the Second Affiliated Hospital of Zhengzhou University, China, between January 2022 and December 2023. Participants were stratified into high and low BMI/TP groups based on a threshold of 0.5. Clinical characteristics and biochemical parameters were compared between groups. Cox proportional hazards models were applied to evaluate the association between the BMI/TP ratio and pregnancy survival, adjusting for relevant covariates. Subgroup analyses assessed potential effect modification by age, obesity, and comorbidities. Among 306 pregnant women (mean age = 31.8 ± 5.6 years), those with higher BMI/TP ratios exhibited significantly greater BMI, serum albumin, C-reactive protein, and total protein levels (all P < .05). Restricted cubic spline analysis demonstrated a nonlinear, U-shaped association between BMI/TP ratio and pregnancy survival (P for nonlinearity < .01). Both low (<0.4) and high (>0.5) BMI/TP ratios were associated with an increased risk of adverse pregnancy outcomes, whereas moderate ratios (approximately 0.4-0.5) showed the lowest mortality risk. These associations remained significant in multivariable Cox regression (hazard ratio = 0.30, 95% confidence interval 0.16-0.57, P < .001) and were consistent across subgroups defined by obesity, maternal age ≥35 years, and comorbid disease. The BMI/TP ratio is a simple and cost-effective biomarker that reflects the balance between maternal metabolic and nutritional status. It demonstrates a nonlinear, U-shaped association with pregnancy survival in gestational hypertension, indicating that both nutritional deficiency and metabolic excess may contribute to adverse outcomes. This ratio may serve as a useful prognostic indicator for individualized risk assessment and clinical management in hypertensive pregnancies.

Related Concept Videos

Regression Toward the Mean01:52

Regression Toward the Mean

Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when...
6.8K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.2K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.1K
Hazard Ratio01:12

Hazard Ratio

The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
543
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
375
Pre-Procedural Guidelines for Assessing Blood Pressure01:10

Pre-Procedural Guidelines for Assessing Blood Pressure

Accurate blood pressure assessment is crucial for diagnosing and managing various health conditions. To ensure the reliability of these measurements, healthcare professionals must adhere to standardized pre-procedural guidelines. These guidelines enhance patient safety and improve the overall quality of healthcare. The following steps are essential for obtaining accurate and consistent blood pressure readings, from using the appropriate tools to ensuring effective communication with the...
783